Sina M, Pedram M, Ghojazadeh
M, Kochaki A, Aghbali A. P53
gene codon 72 polymorphism
in patients with oral squamous cell carcinoma in the population of northern Iran. Med Oral Patol Oral Cir Bucal.
2014 Nov 1;19
(6):e550-5.
doi:10.4317/medoral.19794
http://dx.doi.org/doi:10.4317/medoral.19794
|
1. Shen H, Zheng Y, Sturgis EM,
Spitz MR, Wei Q. P53 codon 72 polymorphism and risk
of squamous cell carcinoma of the head and neck: a
case-control study. Cancer Lett. 2002;183:123-30. |
|
|
|
|
|
2. Levine
AJ. p53, the cellular gatekeeper for growth and division. Cell. 1997;88:323-31. |
|
|
|
|
|
3. Hanel W, Moll UM. Links between mutant p53 and genomic
instability. Journal of cellular biochemistry.
2012;113:433-9. |
|
|
|
|
|
4. Storey
A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, et al.
Role of a p53 polymorphism in the development of human papillomavirus-associated
cancer. Nature. 1998;393:229-34. |
|
|
|
|
|
5. Katiyar S, Thelma BK, Murthy NS, Hedau
S, Jain N, Gopalkrishna V, et al. Polymorphism of
the p53 codon 72 Arg/Pro
and the risk of HPV type 16/18-associated cervical and oral cancer in India. Mol Cell Biochem.
2003;252:117-24. |
|
|
|
|
|
6. Zhu ZZ,
Wang AZ, Jia HR, Jin XX, He XL, Hou
LF, et al. Association of the TP53 codon 72
polymorphism with colorectal cancer in a Chinese population. Japanese journal
of clinical oncology. 2007;37:385-90. |
|
|
|
|
|
7. Soulitzis N, Sourvinos G, Dokianakis DN, Spandidos DA. p53 codon 72 polymorphism and
its association with bladder cancer. Cancer Lett.
2002;179:175-83. |
|
|
|
|
|
8. Wang-Gohrke S, Becher H, Kreienberg R, Runnebaum IB,
Chang-Claude J. Intron 3 16 bp
duplication polymorphism of p53 is associated with an increased risk for
breast cancer by the age of 50 years. Pharmacogenetics. 2002;12:269-72. |
|
|
|
|
|
9. Wirtenberger M, Frank B, Hemminki
K, Klaes R, Schmutzler
RK, Wappenschmidt B, et al. Interaction of Werner
and Bloom syndrome genes with p53 in familial breast cancer. Carcinogenesis.
2006;27:1655-60. |
|
|
|
|
|
10. Thomas
M, Kalita A, Labrecque S,
Pim D, Banks L, Matlashewski
G. Two polymorphic variants of wild-type p53 differ biochemically and biologically.
Molecular and cellular biology. 1999;19:1092-100. |
|
|
|
|
|
11. Sargeran K, Murtomaa H, Safavi SM, Vehkalahti M, Teronen O. Malignant oral tumors in iran:
ten-year analysis on patient and tumor characteristics of 1042 patients in
Tehran. The Journal of craniofacial surgery. 2006;17:1230-3. |
|
|
|
|
|
12. Andisheh-Tadbir A, Mehrabani D,
Heydari ST. Epidemiology of squamous
cell carcinoma of the oral cavity in Iran. The Journal of craniofacial
surgery. 2008;19:1699-702. |
|
|
|
|
|
13. Falaki F, Dalirsani Z, Pakfetrat A, Falaki A, Saghravanian N, Nosratzehi T,
et al. Clinical and histopathological analysis of
oral squamous cell carcinoma of young patients in
Mashhad, Iran: a retrospective study and review of literature. Medicina oral, patologia oral y cirugia bucal. 2011;16:e473-7. |
|
|
|
|
|
14. Marin
MC, Jost CA, Brooks LA, Irwin MS, O'Nions J, Tidy JA, et al. A common polymorphism acts as
an intragenic modifier of mutant p53 behaviour. Nature genetics.
2000;25:47-54. |
|
|
|
|
|
15. Gudleviciene Z, Didziapetriene
J, Ramael M, Uleckiene S,
Valuckas KP. Human papillomavirus
and p53 polymorphism in Lithuanian cervical cancer patients. Gynecologic oncology. 2006;102:530-3. |
|
|
|
|
|
16. Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV,
Hainaut P, et al. Impact of mutant p53 functional properties on TP53 mutation
patterns and tumor phenotype: lessons from recent developments in the IARC
TP53 database. Human mutation. 2007;28:622-9. |
|
|
|
|
|
17. Brant
O, Hoffmann M, Kanappilly A, Gorogh
T, Gottschlich S. P53 codon
72 polymorphism in squamous cell carcinoma of the
head and neck region. Anticancer research. 2007;27:3301-5. |
|
|
|
|
|
18. Liu G,
Miller DP, Zhou W, Thurston SW, Fan R, Xu LL, et
al. Differential association of the codon 72 p53
and GSTM1 polymorphisms on histological subtype of non-small cell lung
carcinoma. Cancer research. 2001;61:8718-22. |
|
|
|
|
|
19. Twu CW, Jiang RS, Shu CH, Lin
JC. Association of p53 codon 72 polymorphism with
risk of hypopharyngeal squamous
cell carcinoma in Taiwan. J Formos
Med Assoc. 2006;105:99-104. |
|
|
|
|
|
20.
Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DF. A systematic review of
genetic polymorphisms and breast cancer risk. Cancer epidemiology,
biomarkers & prevention.
1999;8:843-54. |
|
|
|
|
|
21. Humbey O, Cairey-Remonnay S, Guérrini JS, Algros MP, Mougin C, Bittard H, et al.
Detection of the human papillomavirus and analysis
of the TP53 polymorphism of exon 4 at codon 72 in penile squamous
cell carcinomas. Eur J Cancer. 2003;39:684-90. |
|
|
|
|
|
22. Suzuki
K, Matsui H, Ohtake N, Nakata S, Takei T, Nakazato H, et al. A p53 codon
72 polymorphism associated with prostate cancer development and progression
in Japanese. Journal of biomedical science.
2003;10:430-5. |
|
|
|
|
|
23. Zhang
ZW, Newcomb P, Hollowood A, Feakins
R, Moorghen M, Storey A, et al. Age-associated
increase of codon 72 Arginine
p53 frequency in gastric cardia and non-cardia adenocarcinoma. Clinical cancer research. 2003;9:2151-6. |
|
|
|
|
|
24. Hamel
N, Black MJ, Ghadirian P, Foulkes
WD. No association between P53 codon 72
polymorphism and risk of squamous cell carcinoma of
the head and neck. British journal
of cancer. 2000;82:757-9. |
|
|
|
|
|
25. Summersgill KF, Smith EM, Kirchner HL, Haugen TH, Turek LP. p53 polymorphism,
human papillomavirus infection in the oral cavity,
and oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90:334-9. |
|
|
|
|
|
26. Bau
DT, Tsai MH, Lo YL, Hsu
CM, Tsai Y, Lee CC, et al. Association of p53 and p21(CDKN1A/WAF1/CIP1)
polymorphisms with oral cancer in Taiwan patients. Anticancer research.
2007;27:1559-64. |
|
|
|
|
|
27. Sankaranarayanan R. Oral cancer in India: an
epidemiologic and clinical review. Oral Surg Oral
Med Oral Pathol. 1990;69:325-30. |
|
|
|
|
|
28. Jovanovic A, Schulten EA, Kostense PJ, Snow GB, van der
Waal I. Squamous cell carcinoma of the lip and oral
cavity in The Netherlands; an epidemiological study of 740 patients. J Craniomaxillofac Surg.
1993;21:149-52. |
|
|
|
|
|
29. Otoh EC, Johnson NW, Olasoji
HO, Danfillo IS, Adeleke
OA. Intra-oral carcinomas in Maiduguri, north-eastern Nigeria. Oral Dis. 2005;11:379-85. |
|
|
|
|
|
30. Chidzonga MM. Oral malignant neoplasia:
a survey of 428 cases in two Zimbabwean hospitals. Oral oncology. 2006;42:177-83. |
|
|
|
|
|
31. Izarzugaza
MI, Esparza H, Aguirre JM. Epidemiological aspects of oral and pharyngeal cancers in the Basque
Country. J Oral Pathol Med. 2001;30:521-6. |
|
|
|
|